BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10757089)

  • 1. Apoptosis and pathogenesis of viral hepatitis C--an update.
    Nasir A; Arora HS; Kaiser HE
    In Vivo; 2000; 14(1):297-300. PubMed ID: 10757089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
    Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
    Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C.
    Hiramatsu N; Hayashi N; Katayama K; Mochizuki K; Kawanishi Y; Kasahara A; Fusamoto H; Kamada T
    Hepatology; 1994 Jun; 19(6):1354-9. PubMed ID: 7514559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of the fas system in hepatitis C virus recurrence after liver transplantation.
    Crespo J; Rivero M; Mayorga M; Fabrega E; Casafont F; Gomez-Fleitas M; Pons-Romero F
    Liver Transpl; 2000 Sep; 6(5):562-9. PubMed ID: 10980054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of in vivo blockade of Fas- and TNFR1-mediated hepatocyte apoptosis by the hepatitis C virus.
    Rubbia-Brandt L; Taylor S; Gindre P; Quadri R; Abid K; Spahr L; Negro F
    J Pathol; 2002 Aug; 197(5):617-23. PubMed ID: 12210081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytokine mediators in acute inflammation and chronic course of viral hepatitis].
    Missale G; Ferrari C; Fiaccadori F
    Ann Ital Med Int; 1995; 10(1):14-8. PubMed ID: 7727201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis viruses: live and let die.
    Herzer K; Sprinzl MF; Galle PR
    Liver Int; 2007 Apr; 27(3):293-301. PubMed ID: 17355449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hepatitis C. Analysis of host immune response by immunohistochemistry.
    Marrogi AJ; Cheles MK; Gerber MA
    Arch Pathol Lab Med; 1995 Mar; 119(3):232-7. PubMed ID: 7534056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection.
    Abel M; Sène D; Pol S; Bourlière M; Poynard T; Charlotte F; Cacoub P; Caillat-Zucman S
    Hepatology; 2006 Dec; 44(6):1607-16. PubMed ID: 17133491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of liver T-cell receptor gammadelta T cells obtained from individuals chronically infected with hepatitis C virus (HCV): evidence for these T cells playing a role in the liver pathology associated with HCV infections.
    Tseng CT; Miskovsky E; Houghton M; Klimpel GR
    Hepatology; 2001 May; 33(5):1312-20. PubMed ID: 11343261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8+ T-cell interaction with HCV replicon cells: evidence for both cytokine- and cell-mediated antiviral activity.
    Liu C; Zhu H; Tu Z; Xu YL; Nelson DR
    Hepatology; 2003 Jun; 37(6):1335-42. PubMed ID: 12774012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis in hepatitis C virus infection.
    Bantel H; Schulze-Osthoff K
    Cell Death Differ; 2003 Jan; 10 Suppl 1():S48-58. PubMed ID: 12655346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease.
    Bortolami M; Kotsafti A; Cardin R; Farinati F
    J Viral Hepat; 2008 Jul; 15(7):515-22. PubMed ID: 18331250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of soluble FAS, FAS ligand and tumour necrosis factor-alpha in patients with chronic HCV infection.
    Raghuraman S; Abraham P; Daniel HD; Ramakrishna BS; Sridharan G
    J Clin Virol; 2005 Sep; 34(1):63-70. PubMed ID: 16087126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanism of hepatic injury in coinfection with hepatitis C virus and HIV.
    Balasubramanian A; Koziel M; Groopman JE; Ganju RK
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S32-7. PubMed ID: 16265611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor expression in chronic hepatitis C: correlation with pro-inflammatory cytokine levels and liver injury.
    Riordan SM; Skinner NA; Kurtovic J; Locarnini S; McIver CJ; Williams R; Visvanathan K
    Inflamm Res; 2006 Jul; 55(7):279-85. PubMed ID: 16955390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The -670A > G polymorphism in the promoter region of the FAS gene is associated with necrosis in periportal areas in patients with chronic hepatitis C.
    Aguilar-Reina J; Ruiz-Ferrer M; Pizarro MA; Antiñolo G
    J Viral Hepat; 2005 Nov; 12(6):568-73. PubMed ID: 16255757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
    Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
    J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
    Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
    Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and molecular biology of HCV infection and hepatitis.
    Tang H; Grisé H
    Clin Sci (Lond); 2009 Jun; 117(2):49-65. PubMed ID: 19515018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.